NIYATILEAS

Veerhealth Care Share Price

 

 

Start SIP in NIYATILEAS

Start SIP

Performance

  • Low
  • ₹18
  • High
  • ₹18
  • 52 Week Low
  • ₹9
  • 52 Week High
  • ₹24
  • Open Price₹18
  • Previous Close₹18
  • Volume17,300
  • 50 DMA₹18.28
  • 100 DMA₹18.39
  • 200 DMA₹18.40

Investment Returns

  • Over 1 Month -4.32%
  • Over 3 Month -0.34%
  • Over 6 Month -19.03%
  • Over 1 Year -4.43%

Smart Investing Starts Here Start SIP with Veerhealth Care for Steady Growth!

Invest Now

Veerhealth Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 76.3
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 35
  • P/B Ratio
  • 1.6
  • Average True Range
  • 1.1
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.14
  • RSI
  • 44.62
  • MFI
  • 61.63

Veerhealth Care Financials

Veerhealth Care Technicals

EMA & SMA

Current Price
₹17.70
+ 0.15 (0.85%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹18.09
  • 50 Day
  • ₹18.28
  • 100 Day
  • ₹18.39
  • 200 Day
  • ₹18.40

Resistance and Support

17.82 Pivot Speed
  • R3 18.78
  • R2 18.50
  • R1 18.10
  • S1 17.42
  • S2 17.14
  • S3 16.74

Veerhealth Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results & A.G.M.
2025-05-30 Audited Results & Final Dividend
2025-02-12 Quarterly Results
Date Purpose Remarks
2023-09-22 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Veerhealth Care F&O

Veerhealth Care Shareholding Pattern

No data available.

Veerhealth Care FAQs

Veerhealth Care share price is ₹17 As on 09 February, 2026 | 01:39

The Market Cap of Veerhealth Care is ₹35.4 Cr As on 09 February, 2026 | 01:39

The P/E ratio of Veerhealth Care is 76.3 As on 09 February, 2026 | 01:39

The PB ratio of Veerhealth Care is 1.6 As on 09 February, 2026 | 01:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23